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ReSumo
Estudo de abordagem compreensiva, ob-
jetivou compreender os reflexos e contras-
tes entre o tempo experiencial e o tempo 
protocolar da terapêutica, na vivência 
de mulher jovem com câncer de mama. 
Conformando-se como estudo de situação, 
baseado na História de Vida de Beth, que 
adoeceu e morreu de câncer aos 34 anos, 
empregamos entrevista, observação e aná-
lise do prontuário na recolha dos dados. A 
construção de quadro analítico-sintético, 
com base na cronologia da progressão clí-
nica e fases do tratamento e a percepção 
temporal dos acontecimentos por Beth, 
possibilitou depreender que o tempo pro-
tocolar da terapêutica mostra-se linear, 
marcado pelo sequenciamento do diag-
nóstico e tratamento; já o tempo experien-
cial é marcado pela simultaneidade e não 
linearidade de acontecimentos mobiliza-
dores de intenso sofrimento que o câncer 
produziu na vida de Beth. Tal compreensão 
afirma a necessidade dos profissionais de 
saúde considerarem o tempo vivido pela 
pessoa, conferindo pessoalidade à indis-
pensável terapêutica protocolar do câncer.
DeScRitoReS 
Pequisa qualitativa
Câncer
Eventos que modificam a vida
Cuidados à saúde
ABStRAct
Comprehensive approach study aimed 
understanding the reflections and con-
trasts between personal time and medical 
therapy protocol time in the life of a young 
woman with breast cancer. Addressed as 
a situational study and grounded in Beth’s 
life story about getting sick and dying of 
cancer at age 34, the study’s data collec-
tion process employed interviews, obser-
vation and medical record analysis. The 
construction of the analytic-synthetic box 
based on the chronology of Beth’s clinical 
progression, treatment phases and tempo-
ral perception of occurrences enabled us to 
point out a linear medical therapy protocol 
time identified by the diagnosis and treat-
ment sequencing process. On the other 
hand, Beth’s experienced time was marked 
by simultaneous and non-linear events 
that generated suffering resulting from the 
disease. Such comprehension highlights 
the need for healthcare professionals to 
take into account the time experienced by 
the patient, thus providing an indispens-
able cancer therapeutic protocol with a 
personal character.
DeScRiptoRS 
Qualitative research
Cancer
Life changing event
Health care
ReSumen 
Estudio objetivo conocer los contrastes en-
tre el tiempo de la experiencia y el tiem-
po de tratamiento en la enfermedad por 
cáncer de mama. És basado en la historia 
de vida de Beth, que cayó enferma y mu-
rió de cáncer a los 34 años, uso entrevista, 
observación y análisis de los registros me-
dicos  para tener datos. La construcción de 
la imagen analítico y sintético basado en 
la cronología y progresión del tratamiento 
clínico y la percepción temporal por Beth, 
permitió concluir que el tiempo del proto-
colo se muestra lineal, marcado por la se-
cuenciación del diagnóstico y tratamiento; 
mientra que el tiempo experiencial está 
marcado por simultaneidad y no linealidad 
de los eventos de sufrimiento que el cán-
cer produce en la vida de Beth. Tal enten-
dimiento afirma la necesidad de considerar 
el significado del tiempo para la persona 
enferma, para que tenga un cuidado perso-
nal, esencial en la terapia del cáncer.
DeScRiptoReS 
Investigación cualitativa
Cáncer
Temporalidad
Cuidado de la salud
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intRoDuction
Breast cancer is a type of malign neoplasia that mainly 
affects female populations and whose incidence rates in-
crease every year as a result of changes in lifestyle and 
wider exposure to risk factors. In Brazil, estimates point 
to 570,000 new breast cancer cases in 2014(1); however, 
women still face difficulties regarding early diagnosis and 
efficacy of treatments. It should be highlighted that the 
majority of women affected by breast cancer experiences 
the disease and/or related treatments for years. Treat-
ment may include surgery to eliminate the tumoral mass, 
chemotherapy, radiotherapy, and in some cases, several 
years-long hormone and biological therapies. Following 
the period of treatment, medical follow-up is prescribed, 
encompassing periodic exams for another five years, in 
such a way that the appearance of metastases or recur-
rence of the disease may be prevented(2). Recurrence of 
the disease implies a new therapeutic plan and may call 
for surgery, chemotherapy and radiotherapy, as long as 
they are necessary.
The duration of the disease and related treatments are 
sanctioned by custom in oncology, being dependent upon 
genetic predisposition, type of cancer, health status at 
the time of diagnosis, and organic response to treatment, 
among other factors. As each organism responds in a dif-
ferent way, the proposition of specific therapeutic plans 
and individualized protocols(2) should always be required. 
Such individualization should be a prerequisite for both 
the procedures and drugs to be used, and the temporal 
period of each therapeutic phase.
Therefore, “therapeutic protocol time” follows linear-
chronological temporal logic, based on a parceled, se-
quenced therapeutic process. The medical approach must 
be based on a series of interventions that complies with 
the organic-pathologic response.
Nonetheless, a patient experiencing the cancer dis-
ease process is struck by an avalanche of information and 
pressed to make practical decisions, among them count-
less imposed pilgrimages for treating the disease, the 
need to cope with the reality of potential stigmas, uncer-
tainties concerning effectiveness of treatments, and fear 
of recurrence, eventual mutilation and the concrete pos-
sibility of dying in the process(3). This myriad of staggering 
occurrences generates intense suffering, allied with the 
uncertainty of the treatment results and the continuation 
of life itself.
As a matter of fact, the time experienced by patients 
follows its own temporal logic. Hence, the “experimental 
temporality” born up by patients with cancer needs to be 
apprehended in its intrinsic – variable, unstable, uncertain 
– logic, thus taking into account the way each person per-
ceives and makes sense of experienced time in the pres-
ent, as well as how they combine present issues with past 
events and future plans.
Such temporality is part of an intricate network of 
simultaneous striking occurrences based on which pa-
tients keep on signifying their lives, now on distinct 
grounds. The temporality of experienced time is es-
tranged from sequenced chronologic time. It runs in a 
different mode and is based on reverberations of experi-
ences in which past, present and future are ordained in 
spiral movements(3).
Healthcare practices demand understanding the 
meanings assigned by ill persons to their temporal ex-
perience of disease and treatment processes, in such 
a way that professionals are able to more effectively 
support patients in such painful processes with ef-
fective care. This understanding is shown to be more 
intense when the cancer is deemed to be in chronic 
status, evidencing the conditions under which pa-
tients and their families should be cared for. Chronic 
situations require professionals to comprehend how 
people experience their own disease process, as well 
as the events that insert them into either broader 
or narrower vulnerability circuits, in such a way that 
professionals are able to get closer to the “best care” 
people expect to receive(4). 
The present study addresses Beth’s disease, treat-
ment and dying process. The young woman received 
breast cancer treatment for five years. This experience, 
as narrated by Beth herself in a quite intense way, dra-
matically drew our attention to how she reported “the 
times” of the breast cancer progression and how she 
experienced the treatment to which she was submitted. 
Her reports contradict the time of the treatment proto-
col plan for breast cancer offered to her at the health-
care service. As we, as researchers, were aware of the 
types of organization and sequencing of the different 
treatment protocols for breast cancer, Beth’s reports dis-
turbed us and stimulated us to transform them into the 
focus of the present study.
As such, we primarily aimed at understanding the re-
flections and contrasts between the temporal experience 
and the time of the protocol therapy in the life of a young 
woman with breast cancer.
metHoD
This qualitative research with a comprehensive ap-
proach stands out as a “situational study,”(3) as it ad-
dresses understanding of what goes on in the private 
context of the ill person and her family. In this microreal-
ity, peculiar traits regarding the relationship among the 
various organized patterns built during their lives pro-
duce specific standardized thoughts about the disease 
and caring experience.
The study is based on a master’s dissertation that 
sought to “comprehend the experience of a young woman 
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and her family regarding the disease and dying processes 
caused by breast cancer”.
The participants in the study were Beth, a 34-year-old 
woman diagnosed with breast cancer at 29, and her fam-
ily, composed of Beatriz and Bruna, her adolescent daugh-
ters, and Dona Carlota, her mother. Beth was contacted at 
the reference oncologic institution, located in the State of 
Mato Grosso, Brazil, where she was being treated. Inclu-
sion criteria were: being a patient with a diagnosis of ad-
vanced breast cancer with no medical prognosis of cure; 
being able to express herself verbally; and formally agree-
ing to take part in the study.
In the data collection process, the life history (LH) ap-
proach allowed us to understand Beth’s experiences and 
the meanings she assigned to them(5,6). As expected from 
such a methodological approach, deep understanding of 
the situation was enabled by the establishment of a trust-
ful relationship between the researchers and the patient, 
built throughout nine meetings that occurred between 
October 2011 and May 2012.
It was agreed that this type of study should be 
based on:
[...] the sharing of emotions that makes possible the 
densification of the life history and the reach of several 
different degrees of depth and involvement between 
the researcher and the subject of the research, thus 
turning the telling of the story and the listening pro-
cesses into a mutual relationship of care and human 
growth(7). 
The guiding question for this study was: “Tell us about 
your life, disease and care experience.” The telling of the 
story was shown to be an active work of Beth’s memo-
ries, full of emotions and feelings. Subsequent questions 
were created aimed at broadening the understanding of 
relevant dimensions of her experience. A few interviews 
were recorded; other meetings, due to Beth’s fragile 
health status and her great difficulty with verbal expres-
sion, were reported in detail. The observation process was 
also employed in each meeting, later generating a thor-
ough report of gestures, attitudes, feelings, silences and 
the impressions of the researchers.
The study’s data collection process also used informa-
tion entered into Beth’s medical records by the health-
care institution that performed the treatment. Access 
to the documents was formally authorized. The medical 
records provided some data concerning the various diag-
nostic and therapeutic procedures Beth was submitted 
to throughout five years, beginning with the discovery 
of the cancer in 2006 and ending with her death on De-
cember 8, 2011.
The fully transcribed material resulting from record-
ed meetings, together with the observations carried 
out and the transcription of medical record input, were 
entered into the “research diary”(5) in a Microsoft Word 
file, totaling 86 pages, which constituted our analysis 
corpus.
The analysis consisted of careful and accurate 
reading of all the material. The contrast between the 
times set out by Beth and the times of the breast can-
cer protocol intrigued us. Such disturbances allowed 
us to observe specific meaning units, which in a con-
tinuous and artisanal filtering process enabled us to 
define the thematic axis named “The treatment time 
and the time experienced by a young woman with 
breast cancer,” displayed in the box and discussed in 
the present study.
Ethical norms were fully complied with and the ma-
trix research that generated this study was approved 
by the Research Ethics Committee of the Julio Muller 
University Hospital, under protocol number 671/CEP-
HUJM/09.
ReSuLtS
Comprehension of Beth’s narratives gave evidence of 
the non-linearity of the time experienced by her, show-
ing an “affective” construction of such time and provid-
ing it with a peculiar chaining process. Analysis of the 
medical reports also pointed out a sequenced logic of 
several diagnostic-therapeutic interventions she under-
went. Both of these logics were synthetically organized 
in a descriptive-analytical box (Box 1), aimed at provid-
ing evidence of the diversity with which a similar reality 
can be displayed, meaning the therapeutic protocol and 
Beth’s experienced time.
The sequenced columns in the box show: the chro-
nology of the event inserted into Beth’s medical records, 
expressed in year, month and/or day; the performed in-
tervention denoting the clinical progression of the can-
cer and the treatment phases; and finally the temporal 
perception of these occurrences highlighted in Beth’s 
narratives. Such narrated fragments gave proof of the in-
tensity of the suffering felt by the young woman. These 
fragments are organized in sequence, by ordinal num-
bers and excerpts from the narratives - letters “a” and 
“b,” respectively - in a way that pinpoints them in the 
presentation of the work.
In order to more strongly highlight the intensity of 
what we have called “different temporalities of the ex-
perience,” we preserved Beth’s way of talking about 
the events when transcribing her narratives, emphasiz-
ing the distinct voice intonation whenever she spoke 
about certain terms or expressions regarding her own 
experiences, by which she seemed especially willing 
to underline her experiences, mainly shown by slow-
downs or accelerations in the narrative, with more or 
less intensity.
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Box 1 – Therapeutic protocol time and beth’s experienced time – cuiabá – 2014.
Chronology Clinical progression and treatment 
phases
Beth’s temporal perception of the events
May/2006 1a: breast cancer diagnosis. 1b: [...] then it evolved, suddenly there was that lump that started growing and 
growing... It took SOOOOOOOO long [exam results]... they asked for an ultrasound. 
Then, all of a sudden, it was diagnosed [...] it is complicated, you know you have a 
disease like this. The first thing you can think of is: “Gee, you’re gonna die”.
2a: four chemotherapy rounds aimed at 
reducing tumoral margins.
2b: Then, it all started. First, it was the chemo [...] But what got me mad was not 
the cancer itself, but the treatment, you know. It is quite aggressive... First chemos 
went on and after 14 days I was already hairless. I vomited for 15 days on my bed.
3a: conservative surgery for partial 
removal of the breast.
3b:[...] then, there was the surgery. I underwent the surgery, the first surgery. 
August/2007 4a: six doses of adjuvant chemotherapy 
associated with radiotherapy.
4b: [...] after that, I was stuck in chemotherapy only.
5a: axillary lymph node biopsy to 
confirm local-regional recurrence.
5b: After 30 days, the tumor showed up again. [...] it was 7, 8 cm big, and it grew 
very fast. The type of tumor I have grows, grows very quickly, very quickly indeed 
[emphasis].
6a: radical mastectomy of the left 
breast.
6b: Then, I was operated on again. And once again 30 days later... I had four in 
a row, you know. (referring to the surgeries). And, in the last one, the doctor went 
up to the bone, quite radical indeed.
September/2008 7a: six chemotherapy doses. 7b: I had several chemotherapies, several sessions. Then, the medication was 
replaced, they saw that the tumor did not respond accordingly, then it was 
replaced for another again. They kept on replacing the drugs.
September/2009 8a: evolution to pleura metastasis, six 
chemotherapy rounds.
8b: [...] I can’t stand it, I can’t even walk from here to there [crying], someone has 
to back me up, you understand that?
2009 - 2011 9a: admitted three times in the 
Intensive Care Unit, pleurodesis in two 
of them.
9b: [...] I took 30 mg of methadone, then, from 30 it was increased to 90 mg. I got 
sort of nuts, I even did things I could not remember doing, I was awake and I was 
not aware of it, the next day I could not remember anything. Now, my body has 
gotten used to it, those effects are gone. But the pain is back. I feel terrible pain, 
even before the time for the next medicine comes, the pain is already killing me.
September/2011 10a: admittance, new pleurodesis. 10b: [...] it was placed too high [the drain] and it didn’t work out. It started 
hurting and hurting, so terrible was the pain that I almost died. It was there for 
five days.
October/2011 11a: Beth was required to return to the 
treatment, now deemed to be beyond 
any possibility of being healed. Search 
for another healthcare professional.
11b: Then, doc Jair didn’t want to deal with me anymore. “- Oh, doc Jair, while 
there is life, there is hope. Won’t you even prescribe another chemo?” – “No, I won’t 
prescribe another chemo” [...] Then, I was seen by doc Luis, a chemotherapist, such 
as doc Jair’s specialty, you know. I had to hunt somebody else down. Then I went 
there, he said that for the moment he would not prescribe chemo because I was that 
way, you know [referring to the fatigue, respiratory distress and pain].
Dec 6, 2011 12a: admittance due to intense 
respiratory difficulty.
12b: “What is going on with me?”
Dec 8, 2011 13a: cardiac arrest, death reported at 
6:30 a.m.
13b: Text from Beatriz – “My mother is dead”.
In order to better organize and clarify the ideas pre-
sented here, we initially chose to thoroughly describe the 
box, since it presents different temporalities compared 
with those apprehended by our interpretation of time. 
Later on, we will present the debates with the authors, 
which will enable us to broaden such interpretations.
We contacted Beth in October 2011. At that time she 
was 34 years old. At 29, she realized she had a lump in the 
left breast (box 1, 1b), triggering the search for diagnosis 
and undergoing a number of exams. In her perception, it 
took a very long time for doctors to provide her with a 
response. When describing the search, Beth employed a 
peculiar speed in the narrative, repeating words in order 
to highlight the continuous and accelerated growth of the 
tumor. Sometimes, she sort of chanted the narration of 
the story, expressing the long time between the discovery 
of the lump and the realization of the exam and its result.
In May 2006, Beth was finally given the breast cancer 
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diagnosis (box 1, 1a). Her medical record shows a triple 
negative, stage III tumor. In other words, a locally ad-
vanced tumoral mass larger than five centimeters. This 
type of breast cancer attacks younger women prior to 
menopause, and is generally more aggressive and shows 
the worst prognosis. It corresponds to nearly 15% of all in-
vasive breast cancers and does not respond to treatments 
employing drugs directed to specific molecular targets or 
hormone therapies(8).
When Beth received her diagnosis, she thought it 
meant a death sentence; it was very hard to accept. When 
she talked to us about this phase, after some minutes of 
silence, she resumed her story as if she had taken a breath, 
and said, “Then, it all started…” (box 1, 2b). After that, she 
revealed a tsunami of memories related to her pilgrimages 
in search of therapeutic procedures. These events took 
place during an undefined temporal period; but, for her, 
they seemed to be amassed in a short lapse of time.
In the same year (2006), Beth started receiving che-
motherapy (box 1, 2a) to reduce tumoral bulk prior to the 
surgical procedure. The first round lasted for approximate-
ly three months, in four chemotherapy doses interspersed 
at periods of 21 days. The period encompassed between 
the beginning of the treatment and the first conservative 
surgery to partially remove the left breast is narrated by 
her as if there were a certain abbreviation of time into 
few weeks (box 1, 2b). She packed the beginning of the 
chemotherapy sessions and the performance of the first 
surgery into only one sentence. On the other hand, when 
speaking about the side effects of the chemotherapy, she 
took a long time in the descriptions, highlighting the quick 
hair loss and the coercive vomiting. In this way, she deems 
the treatment to be a disease by affirming, “What got me 
mad is the treatment.”
In August 2007, Beth received six more chemotherapy 
doses interspersed at 21 days; this time, they were associ-
ated with radiotherapy (box 1, 4a). After the end of these 
procedures, and over the six months after the first sur-
gery, Beth’s breast cancer had a local-regional recurrence; 
moreover, new axillary lymph nodes were also detected 
(box 1, 5a). After the confirmatory biopsy, she underwent 
a total mastectomy of the left breast in order to excise the 
tumor along with all correspondent axillary lymph nodes.
The period between the first surgery, the biopsy and the 
total mastectomy was experienced by Beth as a quite con-
densed time, given the turmoil and the intensity of her suf-
fering and her pilgrimages in search of treatment. During 
this period, sequenced and interspersed procedures in the 
temporal calculation of the specific therapeutic protocol 
aimed at her type of cancer were, according to Beth’s per-
spective, resignified as being contiguous events; she elimi-
nated intervals and emphasized the cancer itself, with its 
voracious growth speed. In this way, her narrative employs 
the repetition of words in order to provide a sequence and 
an acceleration to her experienced time (box 1, 5b, 6b).
In this whirlwind of events, Beth realized that she was 
running after something she could not catch or fighting 
against something she could not detain, as “the tumor 
grows, grows very quickly, very quickly indeed.” Beth also 
brought us some allegoric images that gave proof of the 
striking meanings of her experience, such as, “went up to 
the bone, quite radical indeed.” She employed such termi-
nology in order to highlight how extreme her last surgery 
had been and especially her understanding of the cancer 
“embedded in her bones,” much more serious than the 
initial lump.
In September 2008, Beth underwent another chemo-
therapy treatment, once again divided into six sessions 
interspersed at 21 days. From her perspective, being 
submitted to chemotherapy rounds this time meant that 
the tumor “did not work out.” That is why they kept “re-
placing” the employed drugs (box 1, 7b). She expressed, 
therefore, that this experience repeatedly brought back 
her suffering and countless uncertainties.
One year following the last chemotherapy, cancer 
cells were detected in Beth’s lung, and also metastasis in 
her pleura (box 1, 8a), according to what was recorded in 
her medical report. Once again, she was submitted to six 
more chemotherapy doses. However, at this stage, three 
years after the initial diagnosis and after dozens of thera-
py plans, Beth was weak and debilitated. She also devel-
oped a pleural effusion, which made it very difficult for 
her to breathe, resulting in all-day tiredness and the need 
for the support of others in order to carry out any activity 
whatsoever (box 1, 8b).
For over two years, Beth suffered the effects of the 
pleural effusion and needed to be admitted three times to 
the Intensive Care Unit for the realization of a pleurodesis, 
aimed at providing relief to her respiratory difficulty. Ad-
ditionally, she needed to get used to the side effects of the 
sedatives employed to minimize the intense pain, such as 
morphine, which made her feel sleepy during the day and 
forget things she had done or said (box 1, 9b). Beth ex-
pressed her excruciating pain as a “terrible pain” and said 
that “the pain is killing me” (box 1, 9b), also including the 
pain resulting from the medical procedures, such as the 
pleurodesis of September 2011, in which the perception 
of pain was associated with death itself (box 1, 10b).
In October 2011, her doctor informed her of the im-
possibility of keeping up the treatment any longer, given 
her poor general health status (box 1, 11a). Refusing to ac-
cept the doctor’s prognosis, she looked for another medi-
cal professional who, despite not giving her any hope, at 
least did not abandon her for good, stating that he would 
wait for a time in order to try other alternatives (box 1, 
11b). Time, at last, had presented itself as an ally of her 
hope, although no concrete actions could be taken.
On December 6, 2011, Beth was admitted for the last 
time due to intense respiratory distress (box 1, 12a). One 
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day after her admission, now crushed, exhausted and ex-
tremely anxious, she talked to us once again and expressed 
her feelings regarding her health status. We realized, for the 
first time, that she was really willing to know what was hap-
pening, as she repeated quite a few times the same ques-
tion, “What is going on with me?” (box 1, 12b). This time, 
we could give Beth the answer she was so desperately wait-
ing for in a calm, serene and supportive way. Our conversa-
tion following the answer to her question took nearly three 
hours. In it, few words were necessary, showing that time 
could finally go by in a sweeter way for her. On the morning 
of the next day, December 8th, 2011, Beth had a cardiac ar-
rest and died (box 1, 12a). The information was texted to us 
by her daughter Beatriz (box 1, 13b).
It was the end of a short life, although a long and in-
tense one, as Beth had so many stories and experiences 
to share. As her death drew nearer, her experienced mo-
ments of the past were levered to another dimension and 
started having different meanings and times, as she resig-
nified each process by either broadening or concentrat-
ing it amidst much suffering, thus making each moment 
unique.
DiScuSSion
The synthetic box showing the chronology of the can-
cer and highlighting the disease’s clinical advancement 
and the stages of treatment, as well as contrasting the 
disease from Beth’s perspective in experiencing the dis-
ease and treatment process, enabled us to grant visibil-
ity to dimensions otherwise unknown to the researchers. 
The meanings assigned to time by Beth, as if the pains, 
pilgrimages and intense reactions to the countless ther-
apies and procedures had occurred in a short period of 
time, although the treatment process took five long years, 
was clearly evidenced. Obviously, intensely experienced 
suffering seemed to abbreviate time, as it substantially 
spread out and filled Beth’s life, being experienced by her 
as a “condensed temporal period.”
In order to comprehend Beth’s perception concern-
ing her disease and dying process, as well as the evolving 
phases of the cancer and the sequence of the therapeutic 
efforts toward her healing, we find support in the French 
philosopher Gaston Bachelard, as he offers us the idea of 
“sensitive time”. That concept seems to be the closest to 
Beth’s narratives. For Bachelard, away from the homoge-
neity of chronologic time, subjective apprehension of sen-
sitive time is a result of its differentiated extensions, as an 
extension of time can only be identified when an agent 
judges it to be long or short. Even more,
[...] events, therefore, concurrently satisfy and frustrate our 
waiting, justify the continuity of the empty rational location 
and impose the discontinuity of empirical memories […]. 
At contradicting us, events are deeply fixed on our being(9).
As previously highlighted, the temporal period of the 
cancer and its treatment – here called “therapy protocol 
time” - is widely studied, thus making its “drug doses” - 
medication, radiation or surgical procedures - sanctioned 
by custom. Time, therefore, is calculated under a logic 
that is external to the patient. If treatment is “individual-
ized,” it is individualized only concerning the disease, not 
in relation to the patient’s life.
However, despite the diversity of meanings observed 
in experienced time, it is primarily based upon the cancer 
disease and treatment process. The logic of the time ex-
perienced by patients in the turmoil of mobilizing events 
that generate so much suffering certainly misshapes and 
reshapes time in other nonlinear dimensions.
When exhibiting the metaphors of cancer, the au-
thor(10) calls it “a standard euphemism,” as it is character-
ized as a long-term disease that acts slowly and treacher-
ously. Nevertheless, for Beth, this time was experienced 
as a short period. The intensity of the cancer’s growth and 
the voracity of its manifestations, allied with its speed, 
were expressed in a quite emphatic way, a trait that pro-
vided the cancer with a life in itself. Suffering certainly 
overflowed in Beth’s life, sharpening her perceptions 
about abbreviated time adjusted by “intensity of experi-
enced suffering.” Hence, it can be understood that “[...] in 
temporal frames, the being alternatively loses and wins; 
the conscience is either realized or dissolved in it. It is im-
possible, therefore, to experience time being totally root-
ed in the present”(9).
Bearing such logic in mind, Beth’s five years of treat-
ment were so intense and painful that she related to them 
as a whirlwind of events, emphasizing in her own tempo-
rality and under an affective logic of time the recurrence 
of some resignified and remembered procedures. Or, in 
other words, the logic of an event that so deeply affected 
her and pervaded her memories. Hence, although her sto-
ry was narrated to us in the present, she recalled painful 
experiences from the past.
Thus, we understand that the plurality of contradictory 
events may constitute simultaneities that are ordained by 
a proper internal logic(9); in this logic, instead of running, 
time now flows out. And although the time of evolution of 
the cancer and its treatment are more expanded, Beth’s 
perception of the abbreviation of time is a result of the 
direct connections between the disease and the hardships 
she endured in her life.
By contrast, the objective time of the cancer treat-
ment process produces a temporal map grounded on 
the “protocol” within which “a therapeutic plan” must 
be rigorously and sequentially followed up, established 
in days and/or weeks, so that its efficacy is guaranteed. 
In the case of unsatisfactory results, another sequencing 
process is triggered. However, months, days and hours are 
not merely mathematical temporal units, but stages of in-
tense and sensitive experiences. In this way, “the affective 
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character of the duration, the joy or the pain of being, is 
a result of the proportion or disproportion of hours in life 
used either as thinking hours or sympathy hours”(9).
By narrating her experience with her cancer, Beth told 
us about her living in a broader sense; part of her experi-
ence was the disease and dying process as a concrete pos-
sibility. Hence, to live and die were perceived by her as 
temporal perceptions in steady confrontation; if following 
the therapeutic protocol meant getting away from death, it 
also promoted another way of living, calculated by external 
time that should be internalized. And Beth did it with her 
own logic, assigning distinct meanings to each phase of the 
protocol, in the same measure as the suffering she felt. This 
sensitive time experience leads us to understand that:
[...] consciousness of time, for us, is always a conscious-
ness of how we use the moments, it is always active, never 
passive. in a nutshell, the consciousness of our duration is 
the consciousness of a progress of our most inner being, 
be it an effective, imitated or simply dreamed of progress(11).
Although Beth’s submission to the therapeutic proto-
col was passively experienced, that is, based on the proto-
col defined by the healthcare professionals in accordance 
with the specificity of her cancer and her response to each 
proposed plan, she experienced the protocol in a quite 
active way by intensely acting and reacting to the effects 
and suffering the disease brought to her. Therefore, it was 
within the scope of the effects and consequent actions 
and reactions that she set out the calculations of her ex-
perienced time. Within such logic, and only within it, we 
are able to comprehend her narratives, as this was the ex-
perience she was actually talking about.
Thus, it is not up to us to judge and/or confront Beth’s 
protocol and experienced time, but to reveal them, each 
with its own logic, with her disease situation as our back-
ground reality. We also count on Ayres to explain what we 
have been able to apprehend from such experience. That 
author makes it clear that healthcare professionals need 
to establish a relationship with the ill person based on care 
grounds, and not merely on an intervention toward cure:
[...] the way we apply and build scientific technologies 
and knowledge determines boundaries to what we are 
able to see. […] if we also assume that all necessary re-
sponses toward reaching health are not restricted to the 
types of questions that can be formulated by the scientific 
language, then our health care action cannot be bound to 
the mere employment of technologies. our technical inter-
vention has to be articulated with other non-technologic 
aspects. We cannot limit the art of caring for only to the 
creation and manipulation of objects(12).
In this way, we agree that the professional care of a 
human being facing her final moments in life stands out 
as an “attitude-disposition of really and utterly being to-
gether with the other, a special care in the person’s living, 
related to the person’s living and for the person’s living”(7).
concLuSionS
We initially highlighted the advantageous and sensi-
tive employment of the exhibition resource, by means of 
the analytical-synthetic box, regarding the times of the 
evolution of the cancer and the conduct of the thera-
peutic protocol, as well as Beth’s narratives about her 
experiences. Such a strategy, although at a first glance it 
may seem to emphasize the confrontation of such tem-
poral periods, showed a comprehensive potential in this 
study for granting visibility to dimensions that would oth-
erwise not be known. Hence, we were able to highlight 
the meanings assigned by Beth to time, as if her pains, 
pilgrimages and intense reactions to the countless thera-
pies and procedures took place in a personal, condensed 
temporal period, despite the period of five years between 
the diagnosis and her death.
Such visibility reinforced the understanding that life is 
neither linear nor lived in a sequenced shape composed of 
distinct moments. Life is composed of the intertwining of 
experienced events that are closely connected with each 
other, even when they are temporally far away from each 
other, thus reverberating in what we live in the present.
We ratify the need for professionals to take into ac-
count the time experienced by each person, based on the 
intense suffering resulting from the disease and treat-
ment process, thus providing the indispensable thera-
peutic protocol of cancer with a personal nature. For us, 
it is crucial that professionals involved in the care process 
not only aim at the cure, but also allow themselves to 
be guided by human understanding of the patient’s life, 
which also encompasses the disease and dying process as 
constituents of life care.
Finally, we strongly recommend the realization of 
other “situational studies” that can enable professionals 
to apprehend senses and meanings assigned by people to 
their disease, treatment and dying process as a result of 
cancer, pointing out more effective ways of caring for and 
supporting them in their suffering.
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